Humedix Co., Ltd. (200670.KQ)

KRW 40750.0

(1.75%)

Total Assets Summary of Humedix Co., Ltd.

Humedix Co., Ltd.'s latest annual total assets in 2023 was 219.97 Billion KRW , down -3.15% from previous year.
Humedix Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 234.37 Billion KRW , up 1.44% from previous quarter.
Humedix Co., Ltd. reported annual total assets of 227.13 Billion KRW in 2022, up 4.19% from previous year.
Humedix Co., Ltd. reported annual total assets of 217.99 Billion KRW in 2021, up 24.11% from previous year.
Humedix Co., Ltd. reported quarterly total assets of 234.37 Billion KRW for 2024 Q2, up 1.44% from previous quarter.
Humedix Co., Ltd. reported quarterly total assets of 217.22 Billion KRW for 2023 Q3, up 4.78% from previous quarter.

Annual Total Assets Chart of Humedix Co., Ltd. (2023 - 2015)

Historical Annual Total Assets of Humedix Co., Ltd. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	219.97 Billion KRW	-3.15%
2022	227.13 Billion KRW	4.19%
2021	217.99 Billion KRW	24.11%
2020	175.64 Billion KRW	26.89%
2019	138.42 Billion KRW	7.91%
2018	128.27 Billion KRW	-1.13%
2017	129.73 Billion KRW	-1.08%
2016	131.15 Billion KRW	13.17%
2015	115.89 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	231.04 Billion KRW	5.03%
2024 Q2	234.37 Billion KRW	1.44%
2023 Q3	217.22 Billion KRW	4.78%
2023 FY	219.97 Billion KRW	-3.15%
2023 Q2	207.32 Billion KRW	0.5%
2023 Q4	219.97 Billion KRW	1.27%
2023 Q1	206.29 Billion KRW	-9.18%
2022 FY	227.13 Billion KRW	4.19%
2022 Q4	227.13 Billion KRW	3.36%
2022 Q3	219.74 Billion KRW	3.9%
2022 Q2	211.49 Billion KRW	0.19%
2022 Q1	211.1 Billion KRW	-3.16%
2021 FY	217.99 Billion KRW	24.11%
2021 Q3	206.81 Billion KRW	1.98%
2021 Q4	217.99 Billion KRW	5.41%
2021 Q2	202.79 Billion KRW	112399.4%
2021 Q1	180.26 Million KRW	2.63%
2020 Q3	170.54 Million KRW	2.65%
2020 FY	175.64 Billion KRW	26.89%
2020 Q4	175.64 Million KRW	2.99%
2020 Q1	138.12 Million KRW	-0.21%
2020 Q2	166.15 Million KRW	20.29%
2019 Q4	138.42 Million KRW	5.29%
2019 FY	138.42 Billion KRW	7.91%
2019 Q3	131.46 Million KRW	3.68%
2019 Q2	126.8 Million KRW	-3.86%
2019 Q1	131.89 Million KRW	2.82%
2018 Q3	124.57 Million KRW	2.15%
2018 FY	128.27 Billion KRW	-1.13%
2018 Q1	129.55 Million KRW	-0.14%
2018 Q4	128.27 Million KRW	2.97%
2018 Q2	121.96 Million KRW	-5.86%
2017 FY	129.73 Billion KRW	-1.08%
2017 Q4	129.73 Million KRW	0.09%
2017 Q1	129.14 Million KRW	-1.54%
2017 Q2	129.88 Million KRW	0.57%
2017 Q3	129.62 Million KRW	-0.2%
2016 Q4	131.15 Million KRW	0.0%
2016 FY	131.15 Billion KRW	13.17%
2016 Q1	- KRW	0.0%
2015 FY	115.89 Billion KRW	0.0%

Peer Total Assets Comparison of Humedix Co., Ltd.

Name	Total Assets	Total Assets Difference
HLB Pharmaceutical Co., Ltd	141.35 Billion KRW	-55.624%
CMG Pharmaceutical Co., Ltd.	186.85 Billion KRW	-17.728%
Celltrion Pharm, Inc.	641.64 Billion KRW	65.717%
Huons Global Co., Ltd.	1317.96 Billion KRW	83.309%
DongKook Pharmaceutical Co., Ltd.	839.53 Billion KRW	73.798%
Enzychem Lifesciences Corporation	211.54 Billion KRW	-3.986%
Boditech Med Inc.	227.9 Billion KRW	3.477%
EuBiologics Co., Ltd.	172.64 Billion KRW	-27.419%
FutureChem Co.,Ltd	72.83 Billion KRW	-202.03%
Huons Co., Ltd.	537.28 Billion KRW	59.058%
BNC Korea Co., Ltd.	236.15 Billion KRW	6.849%
AptaBio Therapeutics Inc.	92.51 Billion KRW	-137.765%